Biogen moves forward with potential Alzheimer’s drug, seeks US FDA’s approval

Read more

US FDA declines to approve Merck and Eisai’s liver cancer combo therapy

Read more

Coronavirus tricks the body into attacking brain; common heartburn drugs linked to coronavirus risk

Read more

Gilead begins testing inhalable form of remdesivir for COVID-19

Read more

EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source

Read more

Potential COVID-19 vaccine not ‘single solution’ to pandemic, Johnson & Johnson CEO says

Read more

Sami-Sabinsa group’s curcumin c3 complex with bioperine shown to improve cytokine levels

Read more

Cipla launches Cipremi, likely to price it Rs 4,000 per vial

Read more

Premas Biotech initiates triple antigen VLP COVID-19 vaccine candidate for animal trials

Read more

Takeda launches IBD medication Kynteles in India

Read more